Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy

Journal of Clinical Oncology

Volumn 34, Issue 9, 2016, Pages 919-926

  Vora, Ajay ^a   Andreano, Anita ^c   Pui, Ching Hon ^e   Hunger, Stephen P ^f   Schrappe, Martin ⁱ   Moericke, Anja ⁱ   Biondi, Andrea ^c   Escherich, Gabriele ^j   Silverman, Lewis B ^g   Goulden, Nicholas ^b   Taskinen, Mervi ^k   Pieters, Rob ^l   Horibe, Keizo ^m   Devidas, Meenakshi ^h   Locatelli, Franco ^d   Valsecchi, Maria Grazia ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h UNIVERSITY OF FLORIDA   (United States)

ⁱ UNIVERSITY OF KIEL   (Germany)

^j UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^k HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^l Utrecht School   (Netherlands)

^m NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FOLINIC ACID; METHOTREXATE; ANTINEOPLASTIC ANTIMETABOLITE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RECURRENCE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CRANIAL RADIOTHERAPY; EVENT FREE SURVIVAL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; TREATMENT OUTCOME; INFANT; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SECONDARY PREVENTION; SKULL IRRADIATION; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; CRANIAL IRRADIATION; HUMANS; INFANT; LINEAR MODELS; METHOTREXATE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 84962163261     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.64.2850     Document Type: Article

References (30)

1. Chessells JM, Bailey C, Richards SM; Medical Research Council Working Party on Childhood Leukaemia: Intensification of treatment and survival in all children with lymphoblastic leukaemia: Results of UK Medical Research Council trial UKALL X. Lancet 345: 143-148, 1995.
2. Hill FG, Richards S, Gibson B, et al; UK Medical Research Council Working Party on Childhood Leukaemia: Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: Results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172). Br J Haematol 124:33-46, 2004.
3. Pui CH, Campana D, Pei D, et al: Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360:2730-2741, 2009.
4. Vilmer E, Suciu S, Ferster A, et al; Children Leukemia Cooperative Group: Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: A CLCGEORTC report. Leukemia 14:2257-2266, 2000.
5. Halsey C, Buck G, Richards S, et al: The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the riskstratified randomized central nervous system treatment trial MRC UKALL XI. J Hematol Oncol 4:42, 2011.
6. Waber DP, Turek J, Catania L, et al: Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: Findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. J Clin Oncol 25:4914-4921, 2007 [Erratum: J Clin Oncol 26:694, 2008].
7. Chemaitilly W, Li Z, Huang S, et al: Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: A report from the St Jude Lifetime Cohort study. J Clin Oncol 33: 492-500, 2015.
8. Lö ning L, Zimmermann M, Reiter A, et al: Secondary neoplasms subsequent to Berlin-Frankfurt- Mü nster therapy of acute lymphoblastic leukemia in childhood: Significantly lower risk without cranial radiotherapy. Blood 95:2770-2775, 2000.
9. Pui CH, Cheng C, Leung W, et al: Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 349:640-649, 2003.
10. Richards S, Pui CH, Gayon P; Childhood Acute Lymphoblastic Leukemia Collaborative Group (CALLCG): Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 60:185-195, 2013 [Erratum: Pediatr Blood Cancer 60:1729, 2013].
11. Uyttebroeck A, Suciu S, Laureys G, et al; Children's Leukaemia Group (CLG) of the European Organisation for Research and Treatment of Cancer (EORTC): Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: Long term results of the EORTC CLG 58881 trial. Eur J Cancer 44:840-846, 2008.
12. Veerman AJ, Kamps WA, van den Berg H, et al; Dutch Childhood Oncology Group: Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: Results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004). Lancet Oncol 10:957-966, 2009.
13. Vora A, Goulden N, Wade R, et al: Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimalresidual disease (UKALL 2003): A randomised controlled trial. Lancet Oncol 14:199-209, 2013.
14. Kelly MJ, Trikalinos TA, Dahabreh IJ, et al: Cranial radiation for pediatric T-lineage acute lymphoblastic leukemia: A systematic review and metaanalysis. Am J Hematol 89:992-997, 2014.
15. Mö ricke A, Zimmermann M, Reiter A, et al: Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 24:265-284, 2010.
16. Asselin BL, Devidas M, Wang C, et al: Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: A randomized study by the Children's Oncology Group (POG 9404). Blood 118: 874-883, 2011.
17. Borowitz MJ, Devidas M, Hunger SP, et al: Children's Oncology Group: Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A Children's Oncology Group study. Blood 111:5477-5485, 2008.
18. Conter V, Bartram CR, Valsecchi MG, et al: Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: Results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 115:3206-3214, 2010.
19. Escherich G, Trö ger A, Gö bel U, et al: CoALL Study Group, Hamburg, Germany: The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97). Haematologica 96:854-862, 2011.
20. Hasegawa D, Hara J, Suenobu S, et al: 2011 Successful abolition of prophylactic cranial irradiation in children with non-T acute lymphoblastic leukemia (ALL) in the Japan Association of Childhood Leukemia Study (JACLS) ALL-02 Trial. Blood 118:1506, (abstr).
21. Schmiegelow K, Forestier E, Hellebostad M, et al; Nordic Society of Paediatric Haematology and Oncology: Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia 24:345-354, 2010.
22. Schrappe M, Valsecchi MG, Bartram CR, et al: Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: Results of the AIEOP-BFM-ALL 2000 study. Blood 118:2077-2084, 2011.
23. Vrooman LM, Stevenson KE, Supko JG, et al: Postinduction dexamethasone and individualized dosing of Escherichia coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: Results from a randomized study-Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. J Clin Oncol 31:1202-1210, 2013.
24. Andreano A, Rebora P, Valsecchi MG: Measures of single arm outcome inmeta-analyses of rare events in the presence of competing risks. Biom J 57:649-660, 2015.
25. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986.
26. Hamza TH, van Houwelingen HC, Stijnen T: The binomial distribution of meta-analysis was preferred to model within-study variability. J Clin Epidemiol 61:41-51, 2008.
27. Choudhury JB: Non-parametric confidence interval estimation for competing risks analysis: Application to contraceptive data. Stat Med 21: 1129-1144, 2002.
28. Viechtbauer W: Conducting meta-analyses in R with the metafor package. J Stat Softw 36:1-48, 2010.
29. Matloub Y, Lindemulder S, Gaynon PS, et al; Children's Oncology Group: Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: Results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group. Blood 108:1165-1173, 2006.
30. Pui CH, Pei D, Sandlund JT, et al: Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia 24:371-382, 2010.